Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Gains from Sales and Divestitures (2023 - 2025)

Healthcare Triangle's Gains from Sales and Divestitures history spans 3 years, with the latest figure at $583000.0 for Q3 2025.

  • On a quarterly basis, Gains from Sales and Divestitures changed 0.0% to $583000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $583000.0, a 0.0% change, with the full-year FY2024 number at $193451.0, up 58.63% from a year prior.
  • Gains from Sales and Divestitures hit $583000.0 in Q3 2025 for Healthcare Triangle, down from $1.5 million in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for HCTI hit a ceiling of $1.5 million in Q2 2025 and a floor of $48363.0 in Q1 2024.
  • Historically, Gains from Sales and Divestitures has averaged $391084.5 across 3 years, with a median of $157701.5 in 2023.
  • The widest YoY moves for Gains from Sales and Divestitures: up 1403.03% in 2025, down 0.0% in 2025.
  • Tracing HCTI's Gains from Sales and Divestitures over 3 years: stood at $121952.0 in 2023, then soared by 58.63% to $193451.0 in 2024, then surged by 201.37% to $583000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for HCTI at $583000.0 in Q3 2025, $1.5 million in Q2 2025, and $48363.0 in Q1 2025.